Position in PFE
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$799,937
-$151,357 QoQ
Shares Held
33,220
-1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,454
of 2,816 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Sep 30, 2025CallValue
$254
CallShares
10
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WNY Asset Management, LLC holds $12,807,497 across 8 Drug Manufacturers - General names. PFE ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,610 | $6,728,802 | |
| 2 | JNJ |
Johnson & Johnson
|
6,393 | $1,623,630 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,678 | $1,372,123 | |
| 4 | ABBV |
AbbVie Inc.
|
4,347 | $1,093,879 | |
| 5 | PFE |
Pfizer Inc
This page
|
33,220 | $799,937 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,655 | $729,181 | |
| 7 | NVO |
Novo Nordisk A S
|
5,198 | $249,192 | |
| 8 | AMGN |
Amgen Inc
|
582 | $210,753 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $799,937 | 33,220 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $951,294 | 33,878 | Shares | Sole | 2026-05-22 | |
| 2025-09-30 | $254 | 10 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $1,169,328 | 45,892 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $947,808 | 39,101 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $971,865 | 38,353 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $787,569 | 29,686 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $1,121,338 | 38,747 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,108,175 | 39,606 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,049,116 | 37,806 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,238,113 | 43,005 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $1,382,094 | 41,667 | Shares | Sole | 2023-12-14 | |
| 2023-06-30 | $1,322,203 | 36,047 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,519,432 | 37,241 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,979,606 | 38,634 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $1,925,089 | 43,992 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $2,711,732 | 51,721 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,770,730 | 53,520 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $3,050,995 | 51,668 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,066,028 | 48,036 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,756,482 | 44,854 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,540,354 | 42,516 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $1,185,282 | 32,200 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||